Eric Fink

All filings by Eric Fink on record concern Global Blood Therapeutics, Inc., in the capacity of senior executive. The record holds 14 filings, for trades running from 31 July 2020 to 10 May 2021.

In open-market terms, that means 1 purchase worth €16k on one side and 3 sales worth €374k on the other. Netting one side against the other leaves €359k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 6 share grants and 4 option exercises. 2021 to date brings 1 purchase and no sales.

The newest entry dates from 10 May 2021: an open-market purchase of €16k, in Global Blood Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.